Antisense oligonucleotides for treating and/or preventing at least one ofasthma, allergy, hypereosinophilia, general inflammation and cancer areprovided. The oligonucleotides are directed against nucleic acid sequencescoding for a receptor selected from the group consisting of a CCR3 receptorand a common sub-unit of IL-3, IL-5 and GM-CSF receptors.